ProShare Advisors
SANA icon

ProShare Advisors’s Sana Biotechnology SANA Stock Holding History

ProShare Advisors’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$116K Sell
33,172
-3,084
-9% -$9.94K ﹤0.01% 1751
2026
Q1 		$104K Sell
36,256
-5,870
-14% -$23.1K ﹤0.01% 1699
2025
Q4 		$171K Buy
42,126
+10,096
+32% +$45.2K ﹤0.01% 1768
2025
Q3 		$114K Sell
32,030
-3,752
-10% -$13.6K ﹤0.01% 1821
2025
Q2 		$97.7K Sell
35,782
-2,908
-8% -$6K ﹤0.01% 1884
2025
Q1 		$65K Sell
38,690
-9,118
-19% -$25.5K ﹤0.01% 1918
2024
Q4 		$77.9K Buy
47,808
+9,679
+25% +$28.9K ﹤0.01% 2116
2024
Q3 		$159K Buy
38,129
+11,603
+44% +$61K ﹤0.01% 1789
2024
Q2 		$145K Sell
26,526
-6,164
-19% -$49.1K ﹤0.01% 1598
2024
Q1 		$327K Buy
32,690
+4,210
+15% +$31.5K ﹤0.01% 1372
2023
Q4 		$116K Buy
28,480
+3,490
+14% +$12.9K ﹤0.01% 1759
2023
Q3 		$96.7K Buy
24,990
+471
+2% +$2.53K ﹤0.01% 1636
2023
Q2 		$146K Buy
24,519
+820
+3% +$4.73K ﹤0.01% 1617
2023
Q1 		$77.5K Sell
23,699
-3,513
-13% -$14K ﹤0.01% 1627
2022
Q4 		$107K Buy
27,212
+1,397
+5% +$6.83K ﹤0.01% 1639
2022
Q3 		$155K Buy
25,815
+1,045
+4% +$7.54K ﹤0.01% 1460
2022
Q2 		$160K Sell
24,770
-10,943
-31% -$69.7K ﹤0.01% 1525
2022
Q1 		$295K Sell
35,713
-9,743
-21% -$78.8K ﹤0.01% 1641
2021
Q4 		$704K Buy
45,456
+34,390
+311% +$663K ﹤0.01% 1231
2021
Q3 		$249K Buy
+11,066
New +$232K ﹤0.01% 1677

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

ProShare Advisors's SANA Position: Q2 2026 in Review

ProShare Advisors reduced its Sana Biotechnology (SANA) stake by 8.5% in Q2 2026, selling an estimated $9.94K and leaving 33,172 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #1751.

ProShare Advisors first reported a position in SANA in Q3 2021 and has held it in 20 quarters since. The position peaked at $704K in Q4 2021. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • ProShare Advisors held 33,172 shares of Sana Biotechnology worth $116K as of Q2 2026.
  • ProShare Advisors sold 3,084 Sana Biotechnology shares in Q2 2026, an estimated $9.94K.
  • Sana Biotechnology made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #1751 holding.
  • ProShare Advisors first reported a position in Sana Biotechnology in Q3 2021 and has held it in 20 quarters since.
  • ProShare Advisors's Sana Biotechnology position peaked at $704K in Q4 2021.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.